Peter Wiklund, MD, PhD, Director of the Bladder Cancer Program, joined Mount Sinai in 2018 with the goal of building a strong bladder cancer program to complement Mount Sinai’s comprehensive robotic prostate cancer and robotic kidney surgery program.
The Milton and Carroll Petrie Department of Urology at the Icahn School of Medicine at Mount Sinai is a leader in the diagnosis and treatment of bladder cancer and is committed to providing patients access to groundbreaking treatments and techniques.
One of the more recent and significant examples of this approach comes from Peter Wiklund, MD, PhD, Director of the Bladder Cancer Program at the Mount Sinai Health System, who has become one of the first surgeons in the world to use a single-port robot to perform radical cystectomies with a urinary diversion.
Since January 2020, Dr. Wiklund, Professor of Urology at the Icahn School of Medicine and a world-renowned surgeon who pioneered robot-assisted cystectomy, and his team have completed 15 of the single-port procedures using the new da Vinci SP system. Unlike the previous generation four-port robot, it has a single 2.5 cm cannula equipped with a camera and three fully wristed, elbowed instruments, enabling surgery to be performed with a single incision.